Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Medical Specialties
Sector Health Technology
Employees 495
CEO Mr. Timothy R. Damadian
Address 110 Marcus Drive , Melville, NY 11747
Phone 1.631.694.2929
Website www.fonar.com

FONAR Corp. engages in the design, manufacture, sale, and servicing of magnetic resonance imaging scanners. It operates through the Manufacturing and Servicing of Medical Equipment; and Management of Diagnostic Imaging Center segments. The Manufacturing and Servicing of Medical Equipment segment promotes its product, Fonar Upright MRI. The Management of Diagnostic Imaging Center segment offers management, administrative, billing and collection services, office space, equipment, repair, maintenance service and clerical, and non-medical personnel to medical providers through its subsidiary, Health Management Corp. of America. The company was founded by Raymond V. Damadian on July 17, 1978 and is headquartered in Melville, NY.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
FONAR Corp. 0.97% -17.61%
BellRing Brands, Inc. -23.22% 16.22%
ImmunoGen, Inc. -16.49% -8.11%
Heron Therapeutics, Inc. -18.03% -47.42%
Singular Genomics Systems, Inc. -23.64% n/a

Statement Summary

as of 12:58 ET PM 11/26/2021
Total Assets (MRQ) 188.2 M
Total Liabilities (MRQ) 48.8 M
Shareholders’ Equity (MRQ) 139.5 M
Total Revenue (Annual) 23.7 M
Net Income (Annual) 3.9 M

Earnings And Estimates

as of 12:58 ET PM 11/26/2021

Current Qtr EPS Estimate n/a
Current FY EPS Estimate n/a
Long Term EPS Growth Estimate 33.00
Next Expected Earnings Date //

FONR vs S&P 500

as of 11/26/2021
Relative To
S&P 500
FONR
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 11/24/2021
Fiscal Quarter Estimate Actual Surprise

Financial Strength

as of 4:00 ET PM 11/24/2021
Pre-Tax Margin 27.80
Net Margin 37.02
Operating Margin 24.19
Return On Equity 8.55
Return On Assets 6.27
Inventory Turnover (TTM) 27.57
Sales Growth (MRQ) 4.15

Ratios

as of 12:58 PM ET 11/26/2021
Price/Earnings (TTM) 10.25
Price/Book (MRQ) 0.78
Price/Cash Flow (TTM) 6.53
Book Value (MRQ) 21.37
Quick Ratio (MRQ) 6.62
Current Ratio (MRQ) 6.73
Total Debt/Equity (MRQ) 0.23

Short Interest

as of 10:13 AM ET 11/29/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 12:58 ET PM 11/26/2021
Current Qtr
(12/1969)
Next Qtr
(12/1969)
Consensus Estimate n/a n/a
# of Estimates n/a n/a
High Estimate n/a n/a
Low Estimate n/a n/a
Year Ago EPS n/a n/a
Year Over Year Growth Estimate n/a n/a
Current Yr
(12/1969)
Next Yr
(12/1969)
Consensus Estimate n/a n/a
# of Estimates n/a n/a
High Estimate n/a n/a
Low Estimate n/a n/a
Year Ago EPS n/a n/a
Year Over Year Growth Estimate n/a n/a
Current Qtr
(12/1969)
Next Qtr
(12/1969)
Current Year
(12/1969)
Next Year
(12/1969)
Consensus Estimate n/a n/a n/a n/a
# of Estimates n/a n/a n/a n/a
High Estimate n/a n/a n/a n/a
Low Estimate n/a n/a n/a n/a
Year Ago EPS n/a n/a n/a n/a
Year Over Year Growth Estimate n/a n/a n/a n/a

Insider Information Summary

as of 10/31/2021
% Insiders - 3.82%
% Remaining Total Shares - 96.18%
Current 1 Month
Net Insider Transaction 0.00 0.00
Shares Bought 0.00 0.00
Shares Sold 0.00 0.00

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Walmart Lead

Walmart CFO Brett Biggs Leaving After 22 Years

Walmart says Biggs stay on as CFO until a successor is named and will remain as an associate until he leaves in January 2023.

Ready to Trade Bristol-Myers Squibb, Bank of America, CSX? Here's What to Know

Bristol Myers Stock Falls Despite Positive News on Psoriasis Drug

Bristol Myers shares fall after the FDA accepts its psoriasis-treating deucravacitinib drug application, and European regulators also validate its application.

Is Best Buy Stock an Investor Best Buy After Earnings Beat? -- The Charts Speak

Best Buy, Big-Box Store Inventory Strong, Roku Demand High: Wedbush

Wedbush finds no shortage of in-store inventory for consumer electronics. And it says Roku products are in strong demand.

Can Twitter's Jack Dorsey Keep the Good Times Rolling?

Twitter Stock Leaps Amid Report CEO Jack Dorsey Will Step Down

Twitter co-founder Jack Dorsey is set to step-down as CEO of the microblogging website, CNBC reported Monday.

Stock Market Lead

Wells Fargo Bullish on Quality Stocks, Despite Omicron

'We do not recommend de-risking into weakness,' Chris Harvey, head of equity strategy for Wells, writes in a commentary.

Amazon's Potential Delivery Service Not a Reason to Sell FedEx, UPS: Jim Cramer

Amazon Invests in Bypassing Retail Supply Chain Issues

Amazon has built more than 450 new facilities nationwide in recent months in order to beat supply chain issues.

Bitcoin Lead

Cryptocurrency Price Check: Bitcoin Bounces Back After Omicron Scare

Bitcoin 'is leading the market back from the depths of despair,' a cryptocurrency analyst says.

Moderna vaccine Lead

Premarket Movers Monday: Moderna, Zoom Video

Stock futures rose Monday amid travel curbs tied to the omicron Covid variant.

Pfizer Pill Lead

Pfizer Stock Jumps On Plan To Boost Covid Pill Production In Fight Against Omicron Variant

Pfizer CEO Albert Bourla confirmed the drugmaker's plans to boost production of its Paxlovid antivrical treatment in the first against the spread of the new Omicron variant.

Lufax is set to make the biggest splash on the NYSE by a Chinese company since e-commerce giant Alibaba's IPO in 2014. Photo: Reuters

Tech Stocks Lead As Omicron Fears Linger; Pfizer, Moderna, Twitter Move Higher - Stock Market Today

Wall Street looks to rebound from the worst Black Friday session on record Monday as investors continue to track developments in the spread of the newly-discovered Omicron variant.